Latest News

CAP Opens Comment Period for MMR/MSI Testing, Advancing Care for Patients with Cancer

NORTHFIELD, Ill.–(BUSINESS WIRE)– #pathologists–Recognizing a need for evidence-based recommendations to guide molecular testing in the management of patients with cancer, the College of American Pathologists (CAP) and three collaborating societies are developing a clinical guideline for testing DNA mismatch repair (MMR) and microsatellite instability (MSI) status in patients with a range of cancer types. Today, the groups open the public comment period for the guideline “MMR and MSI Testing in Patients Bei

Source link

Related posts

Replacing Eggs, White Toast With Oatmeal For Breakfast May Save Your Life


Here’s How Vitamin B12 Supplements Could Be Deadly


8 Healthy Snacks To Bring On A Road Trip


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy